Complexity of the Genetics and Clinical Presentation of Spinocerebellar Ataxia 17.
Autorzy :
Nethisinghe S; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United Kingdom. Lim WN; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United Kingdom. Ging H; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United Kingdom. Zeitlberger A; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United Kingdom. AbetiR; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United Kingdom. Pemble S; Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, London, United Kingdom. Sweeney MG; Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, London, United Kingdom. Labrum R; Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, London, United Kingdom. Cervera C; Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, London, United Kingdom. Houlden H; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, United Kingdom.; MRC Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, United Kingdom. Rosser E; Department of Clinical Genetics, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom. Limousin P; Sobell Department of Motor Neuroscience and Movement Disorders, UCL Queen Square Institute of Neurology, London, United Kingdom. Kennedy A; Chelsea and Westminster Hospital, London, United Kingdom. Lunn MP; Department of Neuroimmunology, UCL Queen Square Institute of Neurology, London, United Kingdom. Bhatia KP; Sobell Department of Motor Neuroscience and Movement Disorders, UCL Queen Square Institute of Neurology, London, United Kingdom. Wood NW; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United Kingdom. Hardy J; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, United Kingdom.; The Reta Lila Weston Institute of Neurological Studies, UCL Queen Square Institute of Neurology, London, United Kingdom. Polke JM; Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, London, United Kingdom. Veneziano L; Istituto di Farmacologia Traslazionale - National Research Council, Rome, Italy. Brusco A; Department of Medical Sciences, University of Turin, Turin, Italy.; Medical Genetics Unit, Città della Salute e della Scienza University Hospital, Turin, Italy. Davis MB; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United Kingdom. Giunti P; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United Kingdom.
Pokaż więcej
Źródło :
Frontiers in cellular neuroscience [Front Cell Neurosci] 2018 Nov 23; Vol. 12, pp. 429. Date of Electronic Publication: 2018 Nov 23 (Print Publication: 2018).
Calcium Deregulation: Novel Insights to Understand Friedreich's Ataxia Pathophysiology.
Autorzy :
AbetiR; Ataxia Centre, Department of Clinical and Movement Neurosciences, Institute of Neurology, University College London, London, United Kingdom. Brown AF; Ataxia Centre, Department of Clinical and Movement Neurosciences, Institute of Neurology, University College London, London, United Kingdom. Maiolino M; Department of Biomedical Sciences and Public Health, School of Medicine, Università Politecnica delle Marche, Ancona, Italy. Patel S; Department of Cell and Developmental Biology, Division of Biosciences, University College London, London, United Kingdom. Giunti P; Ataxia Centre, Department of Clinical and Movement Neurosciences, Institute of Neurology, University College London, London, United Kingdom.
Pokaż więcej
Źródło :
Frontiers in cellular neuroscience [Front Cell Neurosci] 2018 Oct 02; Vol. 12, pp. 264. Date of Electronic Publication: 2018 Oct 02 (Print Publication: 2018).
Novel Nrf2-Inducer Prevents Mitochondrial Defects and Oxidative Stress in Friedreich's Ataxia Models.
Autorzy :
AbetiR; Ataxia Centre, Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom. Baccaro A; Ataxia Centre, Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom. Esteras N; Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom. Giunti P; Ataxia Centre, Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom.
Pokaż więcej
Źródło :
Frontiers in cellular neuroscience [Front Cell Neurosci] 2018 Jul 17; Vol. 12, pp. 188. Date of Electronic Publication: 2018 Jul 17 (Print Publication: 2018).
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
W koszyku znajdują się zamówienia
W koszyku znajdują się zamówienia do wysłania. Czy chcesz wysłać je do realizacji?
